NM404 as an Imaging Agent in Patients With NSCLC

Completed · Phase 1

Conditions studied: Non Small Cell Lung Cancer

In brief

This study seeks to determine imaging characteristics of radiolabelled 131-I-NM404 in ten patients with cancer, including calculations of PKs, radiation dosimetry, biodistribution, and optimal imaging times (part 1 - complete). In addition, specific tumor accumulation and metabolic fate of 131-I-NM404 will be determined in NSCLC tumors collected in 5 patients (part 2 - complete). Lastly, the study will collect preliminary data on imaging NSCLC tumors in up to 12 patients with evaluable disease (part 3 - ongoing).

Key facts

Study ID

NCT00582283

Run by

University of Wisconsin, Madison

People needed

21

Starts

2004-01-14

Expected to finish

2014-08-01

Last updated by the study team

2019-05-22

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may not qualify if…

• Concomitant infection
• Other active cancers

Where it is running

• University of Wisconsin Carbone Comprehensive Cancer Center — Madison, Wisconsin, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.